Privia Health Group, Inc. (NASDAQ:PRVA - Get Free Report) Director Thomas A. Mccarthy purchased 10,000 shares of the business's stock in a transaction on Thursday, May 23rd. The shares were acquired at an average price of $16.37 per share, for a total transaction of $163,700.00. Following the completion of the purchase, the director now directly owns 52,611 shares of the company's stock, valued at $861,242.07. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.
Privia Health Group Trading Up 5.9 %
Shares of PRVA opened at $17.06 on Friday. The firm has a market capitalization of $2.04 billion, a P/E ratio of 107.40, a PEG ratio of 2.42 and a beta of 0.81. The firm's 50-day moving average is $18.46 and its two-hundred day moving average is $20.67. Privia Health Group, Inc. has a twelve month low of $15.92 and a twelve month high of $29.42.
Privia Health Group (NASDAQ:PRVA - Get Free Report) last released its earnings results on Tuesday, February 27th. The company reported $0.02 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.04 by ($0.02). Privia Health Group had a return on equity of 3.13% and a net margin of 1.11%. The company had revenue of $440.80 million during the quarter, compared to analyst estimates of $425.81 million. During the same period in the prior year, the business posted $0.14 earnings per share. Privia Health Group's revenue was up 21.0% on a year-over-year basis. Analysts predict that Privia Health Group, Inc. will post 0.21 EPS for the current year.
Analyst Upgrades and Downgrades
AI's Next Magnificent Seven
From The Oxford Club | Ad
The Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.
See His Breakdown of the Seven Stocks You Should Own Here.
A number of brokerages recently weighed in on PRVA. TD Cowen dropped their price objective on shares of Privia Health Group from $30.00 to $26.00 and set an "outperform" rating for the company in a report on Friday, March 1st. Truist Financial dropped their price target on shares of Privia Health Group from $28.00 to $24.00 and set a "buy" rating for the company in a research note on Wednesday, May 15th. Evercore ISI reduced their price objective on Privia Health Group from $26.00 to $25.00 and set an "outperform" rating on the stock in a research note on Wednesday, February 28th. Stifel Nicolaus decreased their price objective on Privia Health Group from $28.00 to $24.00 and set a "buy" rating for the company in a research note on Wednesday, May 1st. Finally, Citigroup began coverage on shares of Privia Health Group in a research note on Monday, April 22nd. They set a "buy" rating and a $25.00 target price for the company. Two research analysts have rated the stock with a hold rating and ten have given a buy rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average price target of $25.08.
Get Our Latest Report on Privia Health Group
Institutional Inflows and Outflows
Several hedge funds have recently added to or reduced their stakes in the stock. Advisors Preferred LLC acquired a new stake in shares of Privia Health Group in the fourth quarter valued at about $2,137,000. Loomis Sayles & Co. L P grew its position in Privia Health Group by 1.2% in the third quarter. Loomis Sayles & Co. L P now owns 623,870 shares of the company's stock valued at $14,349,000 after acquiring an additional 7,577 shares in the last quarter. Walleye Capital LLC purchased a new stake in shares of Privia Health Group during the third quarter valued at approximately $1,394,000. Riverbridge Partners LLC lifted its position in shares of Privia Health Group by 8.7% during the fourth quarter. Riverbridge Partners LLC now owns 4,342,385 shares of the company's stock worth $100,005,000 after purchasing an additional 348,852 shares in the last quarter. Finally, Vanguard Group Inc. boosted its stake in shares of Privia Health Group by 0.5% in the third quarter. Vanguard Group Inc. now owns 11,003,989 shares of the company's stock valued at $253,092,000 after purchasing an additional 51,317 shares during the period. 94.48% of the stock is owned by hedge funds and other institutional investors.
About Privia Health Group
(
Get Free Report)
Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
